Niederhafner et al., 2005 - Google Patents
Peptide dendrimersNiederhafner et al., 2005
- Document ID
- 14685946870916295801
- Author
- Niederhafner P
- Šebestík J
- Ježek J
- Publication year
- Publication venue
- Journal of peptide science: an official publication of the European Peptide Society
External Links
Snippet
Dendrimers are branched structures and represent a fast growing field covering many areas of chemistry. Various types of dendrimers differing in composition and structure are mentioned, together with their practical use spanning from catalysis, transport vehicles to …
- 239000000412 dendrimer 0 title abstract description 125
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
- A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Niederhafner et al. | Peptide dendrimers | |
Sadler et al. | Peptide dendrimers: applications and synthesis | |
CA2793087C (en) | Peptides, conjugates and method for increasing immunogenicity of a vaccine | |
Vepřek et al. | Peptide and glycopeptide dendrimers. Part I | |
AU704502B2 (en) | Non-dendritic backbone peptide carrier | |
AU2007327829B2 (en) | Coiled-coil lipopeptide helical bundles and synthetic virus-like particles | |
US20100121029A1 (en) | Anti-hiv immunogenic formulation and process for preparation thereof | |
CA2270869A1 (en) | Constrained helical peptides and methods of making same | |
Abdel-Aal et al. | Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components | |
Monso et al. | Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens | |
TW202130363A (en) | Mutant RSV F protein and use thereof | |
JPH03503539A (en) | Dendritic polymer of multiantigenic peptides useful as antimalarial vaccines | |
JPH05505188A (en) | synthetic polypeptide | |
EP0427768A1 (en) | Polypeptide pertussis toxin vaccine | |
Uray et al. | Peptide epitopes: identification and structural modifications of synthetic antigens | |
Garay et al. | Study of various presentation forms for a peptide mimetic of Neisseria meningitidis serogroup B capsular polysaccharide | |
Theisen et al. | Differential antigenicity of recombinant polyepitope-antigens based on loop-and helix-forming B and T cell epitopes | |
Iglesias et al. | Broader cross-reactivity after conjugation of V3 based multiple antigen peptides to HBsAg | |
JP4391827B2 (en) | Immunogenic preparation of variable peptide epitope and method for producing the same | |
Skarlas et al. | Influenza virus H5N1 hemagglutinin (HA) T‐cell epitope conjugates: design, synthesis and immunogenicity | |
AU1906592A (en) | Peptides for use in induction of t cell activation against hiv-1 | |
WO2024111633A1 (en) | Production of antibodies against protein | |
Rojo | Dendritic compounds as immune response modulators. New approaches for vaccine development | |
WO2023178404A1 (en) | Combination of epitopes and use thereof, vaccine construct, method of inducing an immune response, method for the identification of epitopes | |
ZA200405492B (en) | Immunogenic formulations of variable peptidic epitopes and process for preparation thereof. |